These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 18432645

  • 21. Establishing MHC class I peptide motifs.
    Trautwein N, Stevanović S.
    Methods Mol Biol; 2013; 960():159-168. PubMed ID: 23329486
    [Abstract] [Full Text] [Related]

  • 22. Selection of T-cell epitopes from foot-and-mouth disease virus reflects the binding affinity to different cattle MHC class II molecules.
    Haghparast A, Wauben MH, Grosfeld-Stulemeyer MC, van Kooten P, Hensen EJ.
    Immunogenetics; 2000 Jul; 51(8-9):733-42. PubMed ID: 10941845
    [Abstract] [Full Text] [Related]

  • 23. MHC-peptide multimers: tools of choice for detecting and sorting antigen-specific T-cells.
    Lang F, Bodinier M.
    Transfusion; 2001 May; 41(5):687-90. PubMed ID: 11346707
    [No Abstract] [Full Text] [Related]

  • 24. MHC-Peptide Tetramers to Visualize Antigen-Specific T Cells.
    Altman JD, Davis MM.
    Curr Protoc Immunol; 2016 Nov 01; 115():17.3.1-17.3.44. PubMed ID: 27801510
    [Abstract] [Full Text] [Related]

  • 25. MAPPP: MHC class I antigenic peptide processing prediction.
    Hakenberg J, Nussbaum AK, Schild H, Rammensee HG, Kuttler C, Holzhütter HG, Kloetzel PM, Kaufmann SH, Mollenkopf HJ.
    Appl Bioinformatics; 2003 Nov 01; 2(3):155-8. PubMed ID: 15130801
    [Abstract] [Full Text] [Related]

  • 26. Sequence variability analysis of human class I and class II MHC molecules: functional and structural correlates of amino acid polymorphisms.
    Reche PA, Reinherz EL.
    J Mol Biol; 2003 Aug 15; 331(3):623-41. PubMed ID: 12899833
    [Abstract] [Full Text] [Related]

  • 27. Neural network method for predicting peptides that bind major histocompatibility complex molecules.
    Gulukota K, DeLisi C.
    Methods Mol Biol; 2001 Aug 15; 156():201-9. PubMed ID: 11068761
    [No Abstract] [Full Text] [Related]

  • 28. Identification of T-cell epitopes using allele-specific ligand motifs.
    Stevanović S, Rammensee HG.
    Behring Inst Mitt; 1994 Dec 15; (95):7-13. PubMed ID: 7538751
    [Abstract] [Full Text] [Related]

  • 29. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships.
    Hattotuwagama CK, Doytchinova IA, Flower DR.
    Methods Mol Biol; 2007 Dec 15; 409():227-45. PubMed ID: 18450004
    [Abstract] [Full Text] [Related]

  • 30. Class I and class II MHC bind self peptide sets that are strikingly different in their evolutionary characteristics.
    Yeager M, Carrington M, Hughes AL.
    Immunogenetics; 2000 Jan 15; 51(1):8-15. PubMed ID: 10663556
    [Abstract] [Full Text] [Related]

  • 31. A population response analysis approach to assign class II HLA-epitope restrictions.
    Paul S, Dillon MBC, Arlehamn CSL, Huang H, Davis MM, McKinney DM, Scriba TJ, Sidney J, Peters B, Sette A.
    J Immunol; 2015 Jun 15; 194(12):6164-6176. PubMed ID: 25948811
    [Abstract] [Full Text] [Related]

  • 32. Definition of an extended MHC class II-peptide binding motif for the autoimmune disease-associated Lewis rat RT1.BL molecule.
    Wauben MH, van der Kraan M, Grosfeld-Stulemeyer MC, Joosten I.
    Int Immunol; 1997 Feb 15; 9(2):281-90. PubMed ID: 9040010
    [Abstract] [Full Text] [Related]

  • 33. Structural principles that govern the peptide-binding motifs of class I MHC molecules.
    Zhang C, Anderson A, DeLisi C.
    J Mol Biol; 1998 Sep 04; 281(5):929-47. PubMed ID: 9719645
    [Abstract] [Full Text] [Related]

  • 34. Peptide-binding motifs of two common equine class I MHC molecules in Thoroughbred horses.
    Bergmann T, Lindvall M, Moore E, Moore E, Sidney J, Miller D, Tallmadge RL, Myers PT, Malaker SA, Shabanowitz J, Osterrieder N, Peters B, Hunt DF, Antczak DF, Sette A.
    Immunogenetics; 2017 May 04; 69(5):351-358. PubMed ID: 28315936
    [Abstract] [Full Text] [Related]

  • 35. T cell receptor signaling is limited by docking geometry to peptide-major histocompatibility complex.
    Adams JJ, Narayanan S, Liu B, Birnbaum ME, Kruse AC, Bowerman NA, Chen W, Levin AM, Connolly JM, Zhu C, Kranz DM, Garcia KC.
    Immunity; 2011 Nov 23; 35(5):681-93. PubMed ID: 22101157
    [Abstract] [Full Text] [Related]

  • 36. Static energy analysis of MHC class I and class II peptide-binding affinity.
    Davies MN, Flower DR.
    Methods Mol Biol; 2007 Nov 23; 409():309-20. PubMed ID: 18450011
    [Abstract] [Full Text] [Related]

  • 37. Deciphering complex patterns of class-I HLA-peptide cross-reactivity via hierarchical grouping.
    Mukherjee S, Warwicker J, Chandra N.
    Immunol Cell Biol; 2015 Jul 23; 93(6):522-32. PubMed ID: 25708537
    [Abstract] [Full Text] [Related]

  • 38. MHC multimer technology: current status and future prospects.
    Bakker AH, Schumacher TN.
    Curr Opin Immunol; 2005 Aug 23; 17(4):428-33. PubMed ID: 15967654
    [Abstract] [Full Text] [Related]

  • 39. Pan-Specific Prediction of Peptide-MHC Class I Complex Stability, a Correlate of T Cell Immunogenicity.
    Rasmussen M, Fenoy E, Harndahl M, Kristensen AB, Nielsen IK, Nielsen M, Buus S.
    J Immunol; 2016 Aug 15; 197(4):1517-24. PubMed ID: 27402703
    [Abstract] [Full Text] [Related]

  • 40. Energy landscapes of peptide-MHC binding.
    Collesano L, Łuksza M, Lässig M.
    PLoS Comput Biol; 2024 Sep 15; 20(9):e1012380. PubMed ID: 39226310
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.